 | • レポートコード：MRC2102QY6254 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の心不全治療薬市場について種類別（ACEI、アンジオテンシンII受容体遮断薬、ARNI、ベータ遮断薬、アルドステロン拮抗薬、利尿薬）、用途別（駆出率低下、駆出率維持）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・心不全治療薬市場の概要 ・世界の主要地域別心不全治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の心不全治療薬市場規模2015-2026：種類別（ACEI、アンジオテンシンII受容体遮断薬、ARNI、ベータ遮断薬、アルドステロン拮抗薬、利尿薬） ・世界の心不全治療薬市場規模2015-2026：用途別（駆出率低下、駆出率維持） ・心不全治療薬の米国市場規模2015-2020 ・心不全治療薬のヨーロッパ市場規模2015-2020 ・心不全治療薬の中国市場規模2015-2020 ・心不全治療薬の日本市場規模2015-2020 ・心不全治療薬の東南アジア市場規模2015-2020 ・心不全治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・心不全治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・心不全治療薬の市場動向・機会・課題 ・調査の結論 |
Heart failure occurs when your heart muscle doesn’t pump blood as well as it should.
The market is concentrated as Novartis, Pfizer, AstraZeneca , Hikma, Teva etc. Turkey is the largest consumption place in the Turkey and Middle East & Africa market, with a consumption market share nearly 21%.
Market Analysis and Insights: Global Heart Failure Drugs Market
The global Heart Failure Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Heart Failure Drugs Scope and Market Size
The global Heart Failure Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Heart Failure Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Heart Failure Drugs market is segmented into
ACEI
Angiotensin II Receptor Blockers
ARNIs
Beta Blockers
Aldosterone Antagonists
Diuretics
The proportion of ARNIs in 2018 is about 19%.
Segment by Application, the Heart Failure Drugs market is segmented into
Reduced Ejection Fraction
Preserved Ejection Fraction
The most proportion of heart failure drugs is reduced ejection fraction and the sales proportion is 69%.
The Heart Failure Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Heart Failure Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Heart Failure Drugs Market Share Analysis
Heart Failure Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Heart Failure Drugs business, the date to enter into the Heart Failure Drugs market, Heart Failure Drugs product introduction, recent developments, etc.
The major vendors covered:
Novartis
Pfizer
AstraZeneca
Hikma
Teva
Cipla
Merck & Co.
Amgen
Roche
Sun Pharma
Mylan
1 Heart Failure Drugs Market Overview
1.1 Heart Failure Drugs Product Scope
1.2 Heart Failure Drugs Segment by Type
1.2.1 Global Heart Failure Drugs Sales by Type (2020-2026)
1.2.2 ACEI
1.2.3 Angiotensin II Receptor Blockers
1.2.4 ARNIs
1.2.5 Beta Blockers
1.2.6 Aldosterone Antagonists
1.2.7 Diuretics
1.3 Heart Failure Drugs Segment by Application
1.3.1 Global Heart Failure Drugs Sales Comparison by Application (2020-2026)
1.3.2 Reduced Ejection Fraction
1.3.3 Preserved Ejection Fraction
1.4 Heart Failure Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Heart Failure Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Heart Failure Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Heart Failure Drugs Price Trends (2015-2026)
2 Heart Failure Drugs Estimate and Forecast by Region
2.1 Global Heart Failure Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Heart Failure Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Heart Failure Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Heart Failure Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Heart Failure Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Heart Failure Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Heart Failure Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Heart Failure Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Heart Failure Drugs Estimates and Projections (2015-2026)
2.4.3 China Heart Failure Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Heart Failure Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Heart Failure Drugs Estimates and Projections (2015-2026)
2.4.6 India Heart Failure Drugs Estimates and Projections (2015-2026)
3 Global Heart Failure Drugs Competition Landscape by Players
3.1 Global Top Heart Failure Drugs Players by Sales (2015-2020)
3.2 Global Top Heart Failure Drugs Players by Revenue (2015-2020)
3.3 Global Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heart Failure Drugs as of 2019)
3.4 Global Heart Failure Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Heart Failure Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Heart Failure Drugs Players (Opinion Leaders)
4 Global Heart Failure Drugs Market Size by Type
4.1 Global Heart Failure Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Heart Failure Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Heart Failure Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Heart Failure Drugs Price by Type (2015-2020)
4.2 Global Heart Failure Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Heart Failure Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Heart Failure Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Heart Failure Drugs Price Forecast by Type (2021-2026)
5 Global Heart Failure Drugs Market Size by Application
5.1 Global Heart Failure Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Heart Failure Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Heart Failure Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Heart Failure Drugs Price by Application (2015-2020)
5.2 Global Heart Failure Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Heart Failure Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Heart Failure Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Heart Failure Drugs Price Forecast by Application (2021-2026)
6 United States Heart Failure Drugs Market Facts & Figures
6.1 United States Heart Failure Drugs Sales Market Share by Company (2015-2020)
6.2 United States Heart Failure Drugs Sales Market Share by Type (2015-2020)
6.3 United States Heart Failure Drugs Sales Market Share by Application (2015-2020)
7 Europe Heart Failure Drugs Market Facts & Figures
7.1 Europe Heart Failure Drugs Sales Market Share by Company (2015-2020)
7.2 Europe Heart Failure Drugs Sales Market Share by Type (2015-2020)
7.3 Europe Heart Failure Drugs Sales Market Share by Application (2015-2020)
8 China Heart Failure Drugs Market Facts & Figures
8.1 China Heart Failure Drugs Sales Market Share by Company (2015-2020)
8.2 China Heart Failure Drugs Sales Market Share by Type (2015-2020)
8.3 China Heart Failure Drugs Sales Market Share by Application (2015-2020)
9 Japan Heart Failure Drugs Market Facts & Figures
9.1 Japan Heart Failure Drugs Sales Market Share by Company (3015-3030)
9.2 Japan Heart Failure Drugs Sales Market Share by Type (2015-2020)
9.3 Japan Heart Failure Drugs Sales Market Share by Application (2015-2020)
10 Southeast Asia Heart Failure Drugs Market Facts & Figures
10.1 Southeast Asia Heart Failure Drugs Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Heart Failure Drugs Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Heart Failure Drugs Sales Market Share by Application (2015-2020)
11 India Heart Failure Drugs Market Facts & Figures
11.1 India Heart Failure Drugs Sales Market Share by Company (2015-2020)
11.2 India Heart Failure Drugs Sales Market Share by Type (2015-2020)
11.3 India Heart Failure Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Heart Failure Drugs Business
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Business Overview
12.1.3 Novartis Heart Failure Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis Heart Failure Drugs Products Offered
12.1.5 Novartis Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Business Overview
12.2.3 Pfizer Heart Failure Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Heart Failure Drugs Products Offered
12.2.5 Pfizer Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Corporation Information
12.3.2 AstraZeneca Business Overview
12.3.3 AstraZeneca Heart Failure Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 AstraZeneca Heart Failure Drugs Products Offered
12.3.5 AstraZeneca Recent Development
12.4 Hikma
12.4.1 Hikma Corporation Information
12.4.2 Hikma Business Overview
12.4.3 Hikma Heart Failure Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Hikma Heart Failure Drugs Products Offered
12.4.5 Hikma Recent Development
12.5 Teva
12.5.1 Teva Corporation Information
12.5.2 Teva Business Overview
12.5.3 Teva Heart Failure Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Teva Heart Failure Drugs Products Offered
12.5.5 Teva Recent Development
12.6 Cipla
12.6.1 Cipla Corporation Information
12.6.2 Cipla Business Overview
12.6.3 Cipla Heart Failure Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Cipla Heart Failure Drugs Products Offered
12.6.5 Cipla Recent Development
12.7 Merck & Co.
12.7.1 Merck & Co. Corporation Information
12.7.2 Merck & Co. Business Overview
12.7.3 Merck & Co. Heart Failure Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Merck & Co. Heart Failure Drugs Products Offered
12.7.5 Merck & Co. Recent Development
12.8 Amgen
12.8.1 Amgen Corporation Information
12.8.2 Amgen Business Overview
12.8.3 Amgen Heart Failure Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Amgen Heart Failure Drugs Products Offered
12.8.5 Amgen Recent Development
12.9 Roche
12.9.1 Roche Corporation Information
12.9.2 Roche Business Overview
12.9.3 Roche Heart Failure Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Roche Heart Failure Drugs Products Offered
12.9.5 Roche Recent Development
12.10 Sun Pharma
12.10.1 Sun Pharma Corporation Information
12.10.2 Sun Pharma Business Overview
12.10.3 Sun Pharma Heart Failure Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Sun Pharma Heart Failure Drugs Products Offered
12.10.5 Sun Pharma Recent Development
12.11 Mylan
12.11.1 Mylan Corporation Information
12.11.2 Mylan Business Overview
12.11.3 Mylan Heart Failure Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Mylan Heart Failure Drugs Products Offered
12.11.5 Mylan Recent Development
13 Heart Failure Drugs Manufacturing Cost Analysis
13.1 Heart Failure Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Heart Failure Drugs
13.4 Heart Failure Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Heart Failure Drugs Distributors List
14.3 Heart Failure Drugs Customers
15 Market Dynamics
15.1 Heart Failure Drugs Market Trends
15.2 Heart Failure Drugs Opportunities and Drivers
15.3 Heart Failure Drugs Market Challenges
15.4 Heart Failure Drugs Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Heart Failure Drugs Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Heart Failure Drugs Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Heart Failure Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Heart Failure Drugs Sales (MT) by Region (2015-2020)
Table 5. Global Heart Failure Drugs Sales Market Share by Region (2015-2020)
Table 6. Global Heart Failure Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Heart Failure Drugs Revenue Share by Region (2015-2020)
Table 8. Global Heart Failure Drugs Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Heart Failure Drugs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Heart Failure Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Heart Failure Drugs Revenue Share Forecast by Region (2021-2026)
Table 12. Global Heart Failure Drugs (MT) of Key Companies (2015-2020)
Table 13. Global Heart Failure Drugs Sales Share by Company (2015-2020)
Table 14. Global Heart Failure Drugs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Heart Failure Drugs Revenue Share by Company (2015-2020)
Table 16. Global Heart Failure Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heart Failure Drugs as of 2019)
Table 17. Global Heart Failure Drugs Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Heart Failure Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Heart Failure Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Heart Failure Drugs Players
Table 22. Global Heart Failure Drugs Sales (MT) by Type (2015-2020)
Table 23. Global Heart Failure Drugs Sales Share by Type (2015-2020)
Table 24. Global Heart Failure Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Heart Failure Drugs Price (MT) by Type (2015-2020)
Table 26. Global Heart Failure Drugs Sales Share by Type (2021-2026)
Table 27. Global Heart Failure Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Heart Failure Drugs Revenue Share by Type (2021-2026)
Table 29. Global Heart Failure Drugs Price (MT) by Type (2021-2026)
Table 30. Global Heart Failure Drugs Sales (MT) by Application (2015-2020)
Table 31. Global Heart Failure Drugs Sales Share by Application (2015-2020)
Table 32. Global Heart Failure Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Heart Failure Drugs Price (MT) by Application (2015-2020)
Table 34. Global Heart Failure Drugs Sales (MT) by Application (2021-2026)
Table 35. Global Heart Failure Drugs Sales Share by Application (2021-2026)
Table 36. Global Heart Failure Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Heart Failure Drugs Revenue Share by Application (2021-2026)
Table 38. Global Heart Failure Drugs Price (MT) by Application (2021-2026)
Table 39. United States Heart Failure Drugs Sales (MT) by Company (2015-2020)
Table 40. United States Heart Failure Drugs Sales Market Share by Company (2015-2020)
Table 41. United States Heart Failure Drugs Sales (MT) by Type (2015-2020)
Table 42. United States Heart Failure Drugs Sales Market Share by Type (2015-2020)
Table 43. United States Heart Failure Drugs Sales (MT) by Application (2015-2020)
Table 44. United States Heart Failure Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Heart Failure Drugs Sales (MT) by Company (2015-2020)
Table 46. Europe Heart Failure Drugs Sales Market Share by Company (2015-2020)
Table 47. Europe Heart Failure Drugs Sales (MT) by Type (2015-2020)
Table 48. Europe Heart Failure Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Heart Failure Drugs Sales (MT) by Application (2015-2020)
Table 50. Europe Heart Failure Drugs Sales Market Share by Type (2015-2020)
Table 51. China Heart Failure Drugs Sales (MT) by Company (2015-2020)
Table 52. China Heart Failure Drugs Sales Market Share by Company (2015-2020)
Table 53. China Heart Failure Drugs Sales (MT) by Type (2015-2020)
Table 54. China Heart Failure Drugs Sales Market Share by Type (2015-2020)
Table 55. China Heart Failure Drugs Sales (MT) by Application (2015-2020)
Table 56. China Heart Failure Drugs Sales Market Share by Application (2015-2020)
Table 57. Japan Heart Failure Drugs Sales (MT) by Company (2015-2020)
Table 58. Japan Heart Failure Drugs Sales Market Share by Company (2015-2020)
Table 59. Japan Heart Failure Drugs Sales (MT) by Type (2015-2020)
Table 60. Japan Heart Failure Drugs Sales Market Share by Type (2015-2020)
Table 61. Japan Heart Failure Drugs Sales (MT) by Application (2015-2020)
Table 62. Japan Heart Failure Drugs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Heart Failure Drugs Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Heart Failure Drugs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Heart Failure Drugs Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Heart Failure Drugs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Heart Failure Drugs Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Heart Failure Drugs Sales Market Share by Application (2015-2020)
Table 69. India Heart Failure Drugs Sales (MT) by Company (2015-2020)
Table 70. India Heart Failure Drugs Sales Market Share by Company (2015-2020)
Table 71. India Heart Failure Drugs Sales (MT) by Type (2015-2020)
Table 72. India Heart Failure Drugs Sales Market Share by Type (2015-2020)
Table 73. India Heart Failure Drugs Sales (MT) by Application (2015-2020)
Table 74. India Heart Failure Drugs Sales Market Share by Application (2015-2020)
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Heart Failure Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Novartis Heart Failure Drugs Product
Table 79. Novartis Recent Development
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Heart Failure Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Pfizer Heart Failure Drugs Product
Table 84. Pfizer Recent Development
Table 85. AstraZeneca Corporation Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca Heart Failure Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. AstraZeneca Heart Failure Drugs Product
Table 89. AstraZeneca Recent Development
Table 90. Hikma Corporation Information
Table 91. Hikma Description and Business Overview
Table 92. Hikma Heart Failure Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Hikma Heart Failure Drugs Product
Table 94. Hikma Recent Development
Table 95. Teva Corporation Information
Table 96. Teva Description and Business Overview
Table 97. Teva Heart Failure Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Teva Heart Failure Drugs Product
Table 99. Teva Recent Development
Table 100. Cipla Corporation Information
Table 101. Cipla Description and Business Overview
Table 102. Cipla Heart Failure Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Cipla Heart Failure Drugs Product
Table 104. Cipla Recent Development
Table 105. Merck & Co. Corporation Information
Table 106. Merck & Co. Description and Business Overview
Table 107. Merck & Co. Heart Failure Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Merck & Co. Heart Failure Drugs Product
Table 109. Merck & Co. Recent Development
Table 110. Amgen Corporation Information
Table 111. Amgen Heart Failure Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Amgen Description and Business Overview
Table 113. Amgen Heart Failure Drugs Product
Table 114. Amgen Recent Development
Table 115. Roche Corporation Information
Table 116. Roche Heart Failure Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Roche Description and Business Overview
Table 118. Roche Heart Failure Drugs Product
Table 119. Roche Recent Development
Table 120. Sun Pharma Corporation Information
Table 121. Sun Pharma Description and Business Overview
Table 122. Sun Pharma Heart Failure Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Sun Pharma Heart Failure Drugs Product
Table 124. Sun Pharma Recent Development
Table 125. Mylan Corporation Information
Table 126. Mylan Description and Business Overview
Table 127. Mylan Heart Failure Drugs Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Mylan Heart Failure Drugs Product
Table 129. Mylan Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Heart Failure Drugs Distributors List
Table 133. Heart Failure Drugs Customers List
Table 134. Heart Failure Drugs Market Key Trends
Table 135. Heart Failure Drugs Key Opportunities and Drivers
Table 136. Heart Failure Drugs Market Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Heart Failure Drugs Product Picture
Figure 2. Global Heart Failure Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Heart Failure Drugs Market Share by Application in 2020 & 2026
Figure 6. Reduced Ejection Fraction Examples
Figure 7. Preserved Ejection Fraction Examples
Figure 8. Global Heart Failure Drugs Sales (MT) Growth Rate (2015-2026)
Figure 9. Global Heart Failure Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Heart Failure Drugs Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Heart Failure Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Heart Failure Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Heart Failure Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Heart Failure Drugs Sales (MT) Growth Rate (2015-2026)
Figure 15. Europe Heart Failure Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Heart Failure Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Heart Failure Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Heart Failure Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Heart Failure Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Heart Failure Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Heart Failure Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Heart Failure Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Heart Failure Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Heart Failure Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Heart Failure Drugs Players Market Share by Revenue in Heart Failure Drugs 2015 & 2019
Figure 26. Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Heart Failure Drugs Revenue Share by Type (2015-2020)
Figure 28. Global Heart Failure Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Heart Failure Drugs Revenue Share by Application (2015-2020)
Figure 30. Global Heart Failure Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Heart Failure Drugs Sales Market Share by Type in 2019
Figure 32. United States Heart Failure Drugs Sales Market Share by Type in 2019
Figure 33. Europe Heart Failure Drugs Sales Market Share by Company in 2019
Figure 34. Europe Heart Failure Drugs Sales Market Share by Type in 2019
Figure 35. Europe Heart Failure Drugs Sales Market Share by Application in 2019
Figure 36. China Heart Failure Drugs Sales Market Share by Company in 2019
Figure 37. China Heart Failure Drugs Sales Market Share by Type in 2019
Figure 38. China Heart Failure Drugs Sales Market Share by Application in 2019
Figure 39. Japan Heart Failure Drugs Sales Market Share by Company in 2019
Figure 40. Japan Heart Failure Drugs Sales Market Share by Type in 2019
Figure 41. Japan Heart Failure Drugs Sales Market Share by Application in 2019
Figure 42. Southeast Asia Heart Failure Drugs Sales Market Share by Company in 2019
Figure 43. Southeast Asia Heart Failure Drugs Sales Market Share by Type in 2019
Figure 44. Southeast Asia Heart Failure Drugs Sales Market Share by Application in 2019
Figure 45. India Heart Failure Drugs Sales Market Share by Company in 2019
Figure 46. India Heart Failure Drugs Sales Market Share by Type in 2019
Figure 47. India Heart Failure Drugs Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Heart Failure Drugs
Figure 50. Manufacturing Process Analysis of Heart Failure Drugs
Figure 51. Heart Failure Drugs Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
人工心肺装置の世界市場レポート2020 Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation. The classification of artifici…- 心拍数モニターの世界市場レポート2020 Heart rate monitoring devices are used to measure or record heart rate of an individual person. Additionally, heart rate monitors can be very useful in terms of exercise or workout in order to maintain heart rate of an individual such as aerobic and fat burning zone. Chest strap heart rate monitorin…
- 慢性腎臓病治療薬の世界市場レポート2020 Market Analysis and Insights: Global Chronic Kidney Disease Drugs Market The global Chronic Kidney Disease Drugs market size is projected to reach US$ 12450 million by 2026, from US$ 11220 million in 2020, at a CAGR of 1.8% during 2021-2026. Global Chronic Kidney Disease Drugs Scope and Market Size …
- 経カテーテル心臓弁の世界市場レポート2020 The sales volume of transcatheter heart valves is increasing across several healthcare centers due to the growing prevalence of various heart diseases such as cardio valvular diseases, mitral regurgitation, and aortic stenosis require valve replacement. Increasing mortality due to chronic and end-st…
- 麻酔薬・鎮痛薬の世界市場レポート2020 Market Analysis and Insights: Global Anaesthetic Drugs and Pain Drugs Market The global Anaesthetic Drugs and Pain Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Anaesthetic Drugs and Pain Drugs Scope and Market …